[PCRX] YoY Quarter Result on 31-Dec-2017 [#Q4]

Stock
[PCRX] Pacira BioSciences, Inc.
Announcement Date
28-Feb-2018
Financial Year
2017
Quarter
31-Dec-2017 [#Q4]
Profit Trend
QoQ- 160.48%
YoY- 215.66%
Quarter Report
PCRX's Result
PCRX's Financial Summary
View:
Show?
Quarter Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 128,548 122,424 95,115 79,078 72,902 69,320 61,793 12.97%
PBT 12,693 -3,541 8,322 4,630 -3,994 -2,606 5,975 13.36%
Tax -1,821 1,347 37 35 -21 -108 173 -
NP 14,514 -4,888 8,285 4,595 -3,973 -2,498 5,802 16.49%
Tax Rate 14.35% - -0.44% -0.76% - - -2.90% -
Total Cost 114,034 127,312 86,830 74,483 76,875 71,818 55,991 12.57%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin 11.29 -3.99 8.71 5.81 -5.45 -3.60 9.39 3.11%
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS 0.33 -0.12 0.20 0.11 -0.11 -0.07 0.16 12.81%
EPS Diluted 0.32 -0.12 0.20 0.11 -0.11 -0.07 0.14 14.75%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.